North America Health Economics and Outcome Research (HEOR) Services Market Analysis and Forecast by Size, Share, Growth, Trends 2031
North America Health Economics and Outcome Research (HEOR) Services Market Size and Forecast (2021-2031), Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Service (Economic Modelling or Evaluation, Real World Data Analysis and Information System, Market Access Solutions and Reimbursement, Clinical Outcome, Other Services), Service Provider (Contract Research Organizations and Consultancy), and End User (Biotechnology and Pharmaceutical Companies, Healthcare Payers, Government Organizations, and Healthcare Providers)
Historic Data: 2021-2023 | Base Year: 2024 | Forecast Period: 2025-2031- Status : Published
- Report Code : TIPRE00041424
- Category : Life Sciences
- No. of Pages : 126
- Available Report Formats :

The North America health economics and outcome research (HEOR) services market size is expected to reach US$ 1,801.16 million by 2031 from US$ 783.61 million in 2024. The market is estimated to record a CAGR of 12.6% from 2024 to 2031.
Executive Summary and North America Health Economics and Outcome Research (HEOR) Services Market Analysis:
The HEOR services market in North America is segmented into the US, Canada, and Mexico. The US holds the largest market share, followed by Canada. The growth in North America is characterized by growing demand for HEOR services by the healthcare market players, growing support from the government to provide cost-effective healthcare services, increasing strategic developments by the HEOR players to enhance services, and a growing healthcare industry that demands frameworks and guidelines based on real-world data for their business models.
Customize This Report To Suit Your Requirement
Get FREE CUSTOMIZATIONNorth America Health Economics and Outcome Research (HEOR) Services Market: Strategic Insights
-
Get Top Key Market Trends of this report.This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.
North America Health Economics and Outcome Research (HEOR) Services Market Segmentation Analysis:
Key segments that contributed to the derivation of the North America health economics and outcome research (HEOR) services market analysis are service, service provider, and end user.
- Based on service, the North America health economics and outcome research (HEOR) services market is segmented into economic modelling or evaluation, real world data analysis and information system, market access solutions and reimbursement, clinical outcome, and others. The economic modelling or evaluation segment held the largest share of the market in 2024.
- By service provider, the North America health economics and outcome research (HEOR) services market is bifurcated into contract research organizations and consultancy. The contract research organizations segment held a larger share of the market in 2024.
- By end user, the North America health economics and outcome research (HEOR) services market is segmented into biotechnology and pharmaceutical companies, healthcare payers, government organizations, and healthcare providers. The biotechnology and pharmaceutical companies segment held the largest share of the market in 2024.
North America Health Economics and Outcome Research (HEOR) Services Market Report Scope
| Report Attribute | Details |
|---|---|
| Market size in 2024 | US$ 783.61 Million |
| Market Size by 2031 | US$ 1,801.16 Million |
| CAGR (2024 - 2031) | 12.6% |
| Historical Data | 2021-2023 |
| Forecast period | 2025-2031 |
| Segments Covered |
By Service
|
| Regions and Countries Covered |
North America
|
| Market leaders and key company profiles |
|
North America Health Economics and Outcome Research (HEOR) Services Market Players Density: Understanding Its Impact on Business Dynamics
The North America Health Economics and Outcome Research (HEOR) Services Market is growing rapidly, driven by increasing end-user demand due to factors such as evolving consumer preferences, technological advancements, and greater awareness of the product's benefits. As demand rises, businesses are expanding their offerings, innovating to meet consumer needs, and capitalizing on emerging trends, which further fuels market growth.
North America Health Economics and Outcome Research (HEOR) Services Market Outlook
The healthcare industry has significantly evolved since there is an integration of information technology, artificial intelligence, and digital technology. Healthcare digitalization has attracted several technology giants, such as Apple, Inc.; Amazon.com, Inc.; Alphabet Inc., and Microsoft Corporation, to enter the healthcare segments. For instance, Alphabet Inc.'s venture, Google is dedicatedly involved in life sciences, and its other ventures are investing in the healthcare industry. These companies have utilized their capability with technological development and have provided various wearable devices, digital apps, diagnostics technologies, and therapies that keep track of health and fitness.
Electronic medical records, telemedicine, and big data are a few of the healthcare digitalization results. Microsoft Corporation has entered into artificial intelligence, and it is exploring the possibilities of transforming healthcare, genomics, telehealth, cloud computing, and cybersecurity for the healthcare industry.
Constant developments are being made by the core healthcare companies, contributing to the growth of the HEOR services market. For instance, in October 2023, Curavit Clinical Research, a virtual contract research organization (VCRO) specializing in decentralized clinical trials for digital therapeutics, launched a new Health Economics and Outcomes Research Practice. Curavit will integrate HEOR services into clinical trials to gather evidence on the health economic value of novel pharmaceutical products, particularly digital therapeutics, with the aim of accelerating market momentum. Furthermore, Curavit will evaluate the impact and effectiveness of DTx interventions on both individual and population healthcare levels.
North America Health Economics and Outcome Research (HEOR) Services Market Country Insights
Based on country, the North America health economics and outcome research (HEOR) services market comprises the US, Canada, and Mexico. The US held the largest share in 2024.
The US is the largest market for HEOR services and is estimated to continue its dominancy owing to the presence of HEOR service providers, a well-established healthcare industry that provides broader scope for HEOR services, and a growing shift toward well-planned business models by the companies.
Increased research and development investments by the US government and market players are fueling the HEOR services market. According to the National Center for Science and Engineering Statistics (NCSES), businesses contributed US$ 130 billion to research in 2021, which accounted for 49% of all research spending in the US and 22% of all corporate funding for research and development. 77% of all US research and development in 2021 was conducted by businesses, totaling US$ 609 billion.
North America Health Economics and Outcome Research (HEOR) Services Market Company Profiles
Some of the key players operating in the market include PharmaLex GmbH; ICON Plc; IQVIA Holdings Inc; Syneos Health Inc; Optum Inc; Certara Inc.; ExlService Holdings, Inc.; Avalon Health Economics LLC; Axtria, Inc.; and McKesson Corp, among others. These players are adopting various strategies such as expansion, product innovation, and mergers and acquisitions to provide innovative products to their consumers and increase their market share.
North America Health Economics and Outcome Research (HEOR) Services Market Research Methodology:
The following methodology has been followed for the collection and analysis of data presented in this report:
Secondary Research
The research process begins with comprehensive secondary research, utilizing both internal and external sources to gather qualitative and quantitative data for each market. Commonly referenced secondary research sources include, but are not limited to:
- Company websites, annual reports, financial statements, broker analyses, and investor presentations.
- Industry trade journals and other relevant publications.
- Government documents, statistical databases, and market reports.
- News articles, press releases, and webcasts specific to companies operating in the market.
Note:
All financial data included in the Company Profiles section has been standardized to USD. For companies reporting in other currencies, figures have been converted to USD using the relevant exchange rates for the corresponding year.
Primary Research
The Insight Partners conducts a significant number of primary interviews each year with industry stakeholders and experts to validate its data analysis and gain valuable insights. These research interviews are designed to:
- Validate and refine findings from secondary research.
- Enhance the expertise and market understanding of the analysis team.
- Gain insights into market size, trends, growth patterns, competitive dynamics, and future prospects.
Primary research is conducted via email interactions and telephone interviews, encompassing various markets, categories, segments, and sub-segments across different regions. Participants typically include:
- Industry stakeholders: Vice Presidents, business development managers, market intelligence managers, and national sales managers
- External experts: Valuation specialists, research analysts, and key opinion leaders with industry-specific expertise
Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.
Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.
- Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
- PEST and SWOT Analysis
- Market Size Value / Volume - Regional, Country
- Industry and Competitive Landscape
- Excel Dataset
Recent Reports
Testimonials
The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.
RAN KEDEM Partner, Reali Technologies LTDsI requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.
JEAN-HERVE JENN Chairman, Future AnalyticaWe worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.
PIYUSH NAGPAL Sr. Vice President, High Beam GlobalThe Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services
YUKIHIKO ADACHI CEO, Deep Blue, LLC.This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.
JOHN SUZUKI President and Chief Executive Officer, Board Director, BK TechnologiesI wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.
DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.Reason to Buy
- Informed Decision-Making
- Understanding Market Dynamics
- Competitive Analysis
- Identifying Emerging Markets
- Customer Insights
- Market Forecasts
- Risk Mitigation
- Boosting Operational Efficiency
- Strategic Planning
- Investment Justification
- Tracking Industry Innovations
- Aligning with Regulatory Trends
Get Free Sample For